Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphoma

Leuk Lymphoma. 2022 Mar;63(3):551-561. doi: 10.1080/10428194.2021.1998480. Epub 2021 Nov 2.

Abstract

Beyond MYC rearrangement, Burkitt lymphoma (BL) often presents with additional aberrations. Biopsy touch imprints from 72 children with BL were tested with interphase fluorescence in-situ hybridization (i-FISH) for MYC, BCL2, BCL6, IGH, IGK and IGL rearrangements and copy-number aberrations involving 1q21/1p32, 7cen/7q31, 9cen/9p21, 13q14/13q34 and 17cen/17p13. Diploid status deviations were investigated with chromosome enumeration probes. MYC rearrangement was demonstrated in all cases. Additional aberrations included +1q (21/72:29.2%), +7q (14/72:19.4%), 13q- (14/72:19.4%), 9p-(6/72:8.3%) and hyperdiploidy (6/72:8.3%). Advanced clinical stage IV, +7q and 9p- were associated with shorter overall survival, with stage IV and +7q retaining prognostic significance on multivariate analysis. No relapse or death was reported among the hyperdiploid cases. This i-FISH investigation provides information on the genetic profile of BL and may prove valuable for patients with no karyotype analysis. Demonstration of hyperdiploidy could evolve research on clonal evolution pathways and probably identify a subgroup of children with favorable prognosis.

Keywords: Burkitt lymphoma; FISH; children; cytogenetics; hyperdiploidy.

MeSH terms

  • Burkitt Lymphoma* / diagnosis
  • Burkitt Lymphoma* / genetics
  • Burkitt Lymphoma* / pathology
  • Chromosome Aberrations
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Neoplasm Recurrence, Local